Jian Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jian Yang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Aidong Wang
Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Taizhou, China
1 shared publication- Baoning Nian
3D Med Inc, Dept Clin & Translat Med, 158 Xinjunhuan Rd,Pujiang Hi Tech Pk, Shanghai 201114, Peoples R China
1 shared publication - Chao Yang
Taizhou Hosp Zhejiang Prov, Blood Purificat Ctr, Taizhou, Peoples R China
1 shared publication - Dadong Zhang
Department of Clinical and Translational Medicine, 3D Medicines Inc., Shanghai, China
1 shared publication Fabiao Zhang
Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Taizhou, China
1 shared publication- Fabiao Zhang
Key Laboratory of Minimally Invasive Techniques and Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Department of Hepatobiliary Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, China
1 shared publication
Latest Publications
- Open Access
- 1 October 2024
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 13 (10) , 5328-5338
Optimal preservation condition for the extraction of cell-free DNA from bile of patients with biliary tract cancer
Background: Patients with biliary tract cancer (BTC) often have dismal outcomes due to the poor performance of traditional methods for early diagnosis. Recently, bile cell-free DNA (cfDNA) has been reported as a potential liquid biopsy material for BTC diagnosis. However, bile is a complex alkaline aqueous medium, and the proper storage conditions for bile remain to be explored. The aim of this study is to explore the effects of storing bile under various conditions on the stability of bile cfDNA and to determine the optimal conditions, thereby establishing a foundation for the subsequent application of bile cfDNA in liquid biopsy for early diagnostic and prognosis monitoring of patients with malignant BTC. Methods: We evaluated the storage temperature and storage time for the preservation of bile samples. Bile samples were collected in cfDNA tubes with protectant covered inside or regular tubes without, and the stability of bile cfDNA was analyzed during 10 days at room temperature (RT) or after 2 months of storage at low temperatures. Results: Bile cfDNA remained stable for bile samples being collected with cfDNA tubes and stored for 10 days at RT, while degraded with time for the case with regular tubes. When bile samples were collected with cfDNA tubes and stored for 2 months at 4 ℃, bile cfDNA remained stable, however, if collected with regular tubes, bile cfDNA exhibited a slight loss of integrity. No significant difference was observed for 2 months storage at −20 or −80 ℃. Conclusions: Our findings suggested that for bile cfDNA research, bile samples should be collected with cfDNA tubes and it can be transported for short-term shipment at RT, and could be stored at 4 ℃ with cfDNA tubes, or frozen at −20 ℃ with regular tubes.
- 1 October 2024
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 13 (10) , 5328-5338
Open AccessOptimal preservation condition for the extraction of cell-free DNA from bile of patients with biliary tract cancer
Background: Patients with biliary tract cancer (BTC) often have dismal outcomes due to the poor performance of traditional methods for early diagnosis. Recently, bile cell-free DNA (cfDNA) has been reported as a potential liquid biopsy material for BTC diagnosis. However, bile is a complex alkaline aqueous medium, and the proper storage conditions for bile remain to be explored. The aim of this study is to explore the effects of storing bile under various conditions on the stability of bile cfDNA and to determine the optimal conditions, thereby establishing a foundation for the subsequent application of bile cfDNA in liquid biopsy for early diagnostic and prognosis monitoring of patients with malignant BTC. Methods: We evaluated the storage temperature and storage time for the preservation of bile samples. Bile samples were collected in cfDNA tubes with protectant covered inside or regular tubes without, and the stability of bile cfDNA was analyzed during 10 days at room temperature (RT) or after 2 months of storage at low temperatures. Results: Bile cfDNA remained stable for bile samples being collected with cfDNA tubes and stored for 10 days at RT, while degraded with time for the case with regular tubes. When bile samples were collected with cfDNA tubes and stored for 2 months at 4 ℃, bile cfDNA remained stable, however, if collected with regular tubes, bile cfDNA exhibited a slight loss of integrity. No significant difference was observed for 2 months storage at −20 or −80 ℃. Conclusions: Our findings suggested that for bile cfDNA research, bile samples should be collected with cfDNA tubes and it can be transported for short-term shipment at RT, and could be stored at 4 ℃ with cfDNA tubes, or frozen at −20 ℃ with regular tubes.
- 13 August 2017
- Published by Wiley in Anz Journal of Surgery
- Vol. 88 (6) , E522-E525
Laparoscopic hepatectomy combined with endoscopic papillary balloon dilation for complex bile duct stones
Background: We evaluated the feasibility and efficacy of laparoscopic hepatectomy (LH) combined with endoscopic papillary balloon dilation (EPBD) for removing intra‐ and extrahepatic bile duct stones.Methods: A total of 26 patients with intra‐ and extrahepatic bile duct stones underwent LH and EPBD. Selective hemi‐hepatic vascular occlusion was used to complete the LH. EPBD was performed under the guidance of a guidewire, and stones were removed with a stone basket or balloon.Results: A one‐stage LH with EPBD lithotomy was successfully performed in 26 cases. No residual bile duct stones, intestinal or bile duct perforations were found. In addition, no severe post‐operative bleeding, severe pancreatitis or mortality occurred. Post‐operative hyperamylasemia was observed in five cases and bile leakage in one case. Post‐operative hospital stays lasted 7–11 days.Conclusion: LH combined with EPBD applied to intra‐ and extrahepatic bile duct stones was feasible, effective and safe, resulting in rapid recovery and few post‐operative complications.
- 13 August 2017
- Published by Wiley in Anz Journal of Surgery
- Vol. 88 (6) , E522-E525
Laparoscopic hepatectomy combined with endoscopic papillary balloon dilation for complex bile duct stones
Background: We evaluated the feasibility and efficacy of laparoscopic hepatectomy (LH) combined with endoscopic papillary balloon dilation (EPBD) for removing intra‐ and extrahepatic bile duct stones.Methods: A total of 26 patients with intra‐ and extrahepatic bile duct stones underwent LH and EPBD. Selective hemi‐hepatic vascular occlusion was used to complete the LH. EPBD was performed under the guidance of a guidewire, and stones were removed with a stone basket or balloon.Results: A one‐stage LH with EPBD lithotomy was successfully performed in 26 cases. No residual bile duct stones, intestinal or bile duct perforations were found. In addition, no severe post‐operative bleeding, severe pancreatitis or mortality occurred. Post‐operative hyperamylasemia was observed in five cases and bile leakage in one case. Post‐operative hospital stays lasted 7–11 days.Conclusion: LH combined with EPBD applied to intra‐ and extrahepatic bile duct stones was feasible, effective and safe, resulting in rapid recovery and few post‐operative complications.